Beclamide

Beclamide
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

A drug used in the treatment of epilepsy

Beclamide is a medication primarily used in the treatment of epilepsy. It is classified as an anticonvulsant and works by stabilizing the electrical activity in the brain. Beclamide is particularly effective in managing generalized tonic-clonic seizures and partial seizures.

Pharmacology[edit]

Beclamide functions by modulating the activity of neurotransmitters in the brain, which helps to prevent the abnormal electrical discharges that lead to seizures. The exact mechanism of action is not fully understood, but it is believed to involve the enhancement of GABAergic inhibition and the reduction of glutamatergic excitation.

Chemical Properties[edit]

Beclamide is chemically known as 3-chloro-N-ethyl-N-phenylpropanamide. It is a white crystalline powder that is soluble in water and alcohol. The molecular formula is C₁₁H₁₄ClNO, and it has a molecular weight of 211.69 g/mol.

Clinical Use[edit]

Beclamide is used in the management of epilepsy, particularly in patients who experience generalized tonic-clonic and partial seizures. It is often prescribed when other anticonvulsants are not effective or cause undesirable side effects. The dosage of beclamide is tailored to the individual needs of the patient, and it is usually administered orally.

Side Effects[edit]

Common side effects of beclamide include drowsiness, dizziness, and gastrointestinal disturbances such as nausea and vomiting. In some cases, patients may experience allergic reactions, skin rashes, or blood dyscrasias. It is important for patients to be monitored regularly by their healthcare provider while taking beclamide.

History[edit]

Beclamide was first introduced in the mid-20th century as an anticonvulsant. It has been used in various countries for the treatment of epilepsy, although its use has declined with the development of newer anticonvulsants that have more favorable side effect profiles.

Related pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian